The cell-based therapy market will grow significantly, supported by recent clarity in the FDA pathway, improved clinical outcomes as well as market entry by big pharma.
Market Insight: Oded Ben-Joseph, PhD and Echoe Bouta, PhD
The cell-based therapy market will grow significantly, supported by recent clarity in the FDA pathway, improved clinical outcomes as well as market entry by big pharma.
Recent advances in cell-based therapy technology and FDA approvals have demonstrated the feasibility of of treating difficult diseases. Given the progress, we examined recent market dynamics in a 3.5-year period starting in January 2015 by analyzing clinical trials, financing events, M&As and IPOs to assess the overall activity of the sector and interest by venture capitalists and strategic players
Outcome Capital Named Top 10 M&A Consulting Firms December 1, 2022 Outcome Capital leads in Financial Services Review annual listing of 10 companies that are at the forefront of providing Mergers & Acquisitions Consulting services & impacting the marketplace. Read the full article here:
Read MoreOutcome Capital Life Science Market Pulse February 2023 Click to view our LifeSciences Pulse Newsletter
DownloadWould you like to learn more about working with Outcome Capital or discuss your specific needs?